entertainment -WSS

entertainment

author：hotspot 2025-09-30 14:09:06 - browse：7744

A collage illustration with a patient in the center with a hand to the left administering treatment and a doctor in the background. -- health tech coverage from STAT — Katy Lemay for STAT

The makers of minimally invasive surgical devices seemed poised to capture a wide swath of the obesity treatment market. Patients needed an option that lay between the two treatment extremes: cutting open the abdomen to perform permanent bariatric surgery, or changing your diet or exercise routine.

Then, a new class of weight loss medications that successfully mimic the feeling of fullness hit the market, and the landscape changed.

“It turns out that what came along — before those endoscopic devices have really matured — is these new drugs,” said Lee Kaplan, director of Massachusetts General’s obesity institute. Since the Food and Drug Administration approved Novo Nordisk’s Wegovy in 2021, it and similar drugs that followed have swiftly captured the public’s interest — and are on their way to generating billions of dollars in sales.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： It's time to get medical device identifiers over the finish line

focus

hotspot

leisure time

WSS

Alexander Hamilton and the argument for universal insurance

Retired US general questions alleged Putin, Prigozhin meeting

‘We were in the air.’ Mississippi family recounts surviving tornado that tore mobile home apart

Dozens of Pride flags vandalized at Stonewall monument in NYC, 3rd time this month: Police

NIH fellows want a pay raise. Will that mean less money for grants?

Ending health disparities requires full federal government, panel says

knowledge

entertainment

focus

How one medical school became remarkably diverse

'Hero' Louisville officer shot in head at mass shooting discharged over 3 months later

In Memoriam: Notable people who died in 2023

Will biotech layoffs continue through 2023?

Medical leaders decry Supreme Court decision on affirmative action

Ending health disparities requires full federal government, panel says

Continuity nursing helped my family in our darkest PICU moments

Iowa House, Senate pass 6

United colonoscopy coverage change 'may cost lives,' doctors say

Alexander Hamilton and the argument for universal insurance

leisure time

Oak trusses raised to roof of fire

Why 40% Americans with Parkinson’s don’t see a neurologist

Insurance companies sue energy corporation after it was blamed for helping start Colorado wildfire

Biden announces an advanced cancer research initiative

Marc Tessier

The Jan. 6 committee previously recommended Trump be criminally charged. Here's why

focus

hotspot

leisure time

leisure time